Invention Grant
- Patent Title: Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
- Patent Title (中): 人炭疽毒素中和单克隆抗体及其使用方法
-
Application No.: US11072102Application Date: 2005-03-03
-
Publication No.: US07658925B2Publication Date: 2010-02-09
- Inventor: Herman Groen , Christine Cool-Kebbedies , Kunja S. Slopsema , Hans Westra
- Applicant: Herman Groen , Christine Cool-Kebbedies , Kunja S. Slopsema , Hans Westra
- Applicant Address: NL
- Assignee: IQ Therapeutics BV
- Current Assignee: IQ Therapeutics BV
- Current Assignee Address: NL
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Cynthia A. Kozakiewicz
- Main IPC: A61K39/40
- IPC: A61K39/40 ; C12N5/06
Abstract:
The invention fully humanized monoclonal antibodies that neutralize Bacillus anthracis. Also provided are methods of treating or preventing a Bacillus anthracis infection. The invention also provides methods of passive vaccination of a subject against Bacillus anthracis.
Public/Granted literature
- US20060258842A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof Public/Granted day:2006-11-16
Information query
